• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Apelin-13, human/cow

Apelin-13, human/cow

Product ID A6017
Cas No. 217082-60-5
Purity ≥95%
Product Unit SizeCostQuantityStock
0.5 mg $130.80 Please Inquire
1 mg $220.70 Please Inquire
2.5 mg $392.40 Please Inquire
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Apelin-13 is an endogenous peptide that exhibits neuroprotective and pro-angiogenic activities. Apelin-13 binds apelin receptors (APJ receptors) that heterodimerize with bradykinin receptors; upon binding, this complex signals for increases in phosphorylation of eNOS, activation of PKC, and cellular proliferation. Apelin-13 is also involved in the regulation of water balance, food intake, nociception, and cardiovascular responses. In vivo and in vitro, apelin-13 increases myocardial glucose uptake and GLUT4 membrane translocation in an AMPK-dependent manner. In animal models of ischemia/reperfusion, apelin-13 decreases neurological deficits, infarct volume, and brain edema, and also downregulates expression of Bax and caspase 3 through activation of the PI3K/Akt signaling pathway. Additionally, apelin-13 promotes proliferation, migration, and tube formation in myocardial microvascular endothelial cells.

Product Info

Cas No.

217082-60-5

Purity

≥95%

Formula

C69H111N23O16S

Formula Wt.

1550.86

Solubility

Soluble in ethanol (20 mg/mL). Soluble in DMSO (30 mg/mL). Soluble in PBS (10 mg/mL).

Appearance

White to off white powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

A6017 MSDS PDF

Info Sheet

A6017 Info Sheet PDF

References

Yang Y, Zhang X, Cui H, et al. Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways. Neurosci Lett. 2014 Mar 29;568C:44-49. [Epub ahead of print]. PMID: 24686182.

Bo B, Lulu L, Ning Z, et al. Heterodimerization of human apelin and bradykinin 1 receptors: Novel signal transduction characteristics. Cell Signal. 2014 Mar 29. pii: S0898-6568(14)00124-7. [Epub ahead of print]. PMID: 24686079.

Yang X, Zhu W, Zhang P, et al. Apelin-13 stimulates angiogenesis by promoting cross talk between AMP-activated protein kinase and Akt signaling in myocardial microvascular endothelial cells. Mol Med Rep. 2014 May;9(5):1590-6. PMID: 24573187.

Xu S, Han P, Huang M, et al. In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake. Peptides. 2012 Oct;37(2):320-6. PMID: 22906703.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • M3379

    Mitoxantrone Dihydrochloride

    Anthracenedione, DNA intercalator; Pim-1 inhibi...

    ≥98%
  • F4783

    Fluvoxamine Maleate

    FIASMA, 5-HT3 and σ1 agonist, SERT inhibitor.<...

    ≥97%
  • M5756

    Montelukast Sodium

    CysLT1 antagonist.

    ≥98%
  • E7857

    Etofenamate

    NSAID; COX-1/2 and lipoxygenase inhibitor.

    ≥98%
  • I7302

    Isatin

    Indole derivative found in Isatis, Calanthe, an...

    ≥97%
  • H9711

    (Z)-4-Hydroxytamoxifen

    SERM.

    ≥98%
  • S0048

    Salicin

    Alcoholic β-glucoside found in willow bark, sa...

    ≥98%
  • R0272

    Rasagiline Mesylate

    MAO-A/B inhibitor.

    ≥98%
  • I4659

    Iloperidone

    Benzisoxazole phenylethanone; D2 and 5-HT2A ant...

    ≥99%
  • B1898

    Bezafibrate

    Fibrate; PPARα agonist.

    ≥98%
  • M5610

    Moclobemide

    MAO-A inhibitor.

    ≥98%
  • P2818

    Phentolamine Methanesulfonate

    ATP-sensitive K+ channel activator, α-adrenerg...

    ≥98%
  • I4802

    Imatinib Mesylate

    Abl, c-Kit, PDGFR inhibitor.

    ≥98%
  • A5234

    Amisulpride

    5-HT7 and D2/3 antagonist.

    ≥98%
  • N3474

    Nisoldipine

    Calcium channel blocker.

    ≥98%
  • I0518

    I-BET-762

    BRD inhibitor.

    ≥98%
  • C9610

    D-Cycloserine

    NMDA partial agonist, D-Ala-D-Ala ligase inhibi...

    ≥98%
  • B3275

    Bis(3,5-dibromosalicyl) Succinate

    Aspirin analog; hemoglobin chain cross-linker.<...

    ≥95%
  • A528251

    Angiotensin I/II (1-7)(DP-7)

    Peptide fragment

    ≥95%
  • C4517

    Clenbuterol Hydrochloride

    β2-adrenergic agonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only